SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Geron Corp.
An SI Board Since November 1996
Posts SubjectMarks Bans Symbol
3576 157 0 GERN
Emcee:  XenaLives Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3051Geron Initiates Clinical Trial of Telomerase Inhibitor Drug in Patients with Mulbob zagorin-11/28/2007
3050GERN comments.. Recent Advances in Cellular Reprogramming No Impact on Human ESavant-11/21/2007
3049The New York Times November 21, 2007 New Stem Cell Method Could Ease Ethical Cobob zagorin-11/20/2007
3048Journal of Neuroimmunology Publishes Study Results Showing That Geron's HumaLJM-11/13/2007
3047UBS Global Life Sciences Conference Tuesday, September 25, 2007 events.streamx.esammee-9/30/2007
3046It's all in the perspective. Apparently, there are TWO 1/2 full cups. lol BSavant-9/5/2007
3045HUH ? (based on reading only the "headers" from last two messages)Jon Koplik-9/4/2007
3044Pharmexa Loses European Patent Appeal for Broad Claims to Telomerase-Based CanceSavant-9/4/2007
3043Pharmexa Again Prevails Against Geron In Patent Appeal Hoersholm, Denmark, Aug tnsaf-9/4/2007
3042Geron Scientists and Collaborators Demonstrate Human Embryonic Stem Cell-Derivedtnsaf-8/27/2007
3041Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with AcuSavant-7/11/2007
3040Geron Initiates Clinical Trial of Telomerase Inhibitor Drug in Combination With Savant-7/9/2007
3039Seems like a very good report to me. Perhaps it is because it isn't exactly Savant-6/19/2007
3038Today's news seems good, but the market thinks otherwise. I guess investorsJMarcus-6/19/2007
3037From the 8-K (see below), it appears that the restructuring of the TAT joint venJMarcus-6/19/2007
3036Here's Adam Feuerstein's recap of last week's action: A painful lesJMarcus-6/19/2007
3035GERN ups stake to 75% in TAT. HKU owns sub with other 25% Best, S.Savant-6/18/2007
3034Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics nigel bates-6/12/2007
3033Press Release Source: Geron Corporation Research Indicates Geron's Human ELJM-6/11/2007
3032EDIT to prior post. First week of July is deadline for Merck to exercise their LJM-6/6/2007
3031First week of July is deadline for Merck to exercise their option on GRN163L. DLJM-6/5/2007
3030Any connection between the June 11-15 conference and pricing of the ConvertiblesCacaito-6/5/2007
3029Yes, Okarma mentioned presenting at the Pan Pacific Lymphoma Conference, but I hJMarcus-5/23/2007
3028Marc - Thank you so much for taking the time to post your notes. I appreciate iLJM-5/23/2007
3027Here are my mostly raw notes from this year’s stockholders meeting, which was heJMarcus-5/23/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News